MedTrace Logo

Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study

NCT05534555 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-09-09

No results posted yet for this study

Summary

This is a mixed-methods, multi-centre feasibility study. Formal advice and peer-review with regards to study design was sought from the Southampton Research Design Service (RDS), the NIHR CRN Wessex, and patient contributors during the development of the grant application. We will recruit up to ten GP practices, each given 20-40 FebriDx tests (300 in total). Up to four clinicians per practice will be trained to use the test. A sequential explanatory approach to data collection will be taken (21), with quantitative data analysis in stage one, followed by qualitative interviews with the study's practice participants in stage two.

Conditions

  • Lower Resp Tract Infection

Interventions

DIAGNOSTIC_TEST

FebriDx

Testing of finger-prick blood sample using FebriDx

Sponsors & Collaborators

  • University of Southampton

    lead OTHER

Principal Investigators

  • Christopher Wilcox · University of Southampton

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-10-31
Completion
2024-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534555 on ClinicalTrials.gov